Trang kết quả 12 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1011)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (737)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (10)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2608)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2608)
Công nghệ sinh học (2608)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2608)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1702)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (554)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (420)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (502)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $658.88 133.54 USD |
+0.86
|
$680.1B 137.85B USD | $6 1.22 USD | $658.88 133.54 USD | $662.3 134.24 USD | $680.1B 137.85B USD | 31.04 | $21.22 4.3 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,565.3 507.17 USD |
-0.76
|
$2.23T 132.07B USD | $16 0.95 USD | $8,565.3 507.17 USD | $8,565.3 507.17 USD | $2.23T 132.07B USD | 30.12 | $284.37 16.84 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $97.01 19.66 USD |
+0.6
|
$641.35B 129.99B USD | $114 23.11 USD | $97.01 19.66 USD | $97.75 19.81 USD | $641.35B 129.99B USD | 31.29 | $3.1 0.63 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $19,263.59 1140.64 USD |
-0.73
|
$2.14T 126.45B USD | $52 3.08 USD | $19,263.59 1140.64 USD | $19,263.59 1140.64 USD | $2.14T 126.45B USD | 30.86 | $624.14 36.96 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $441.35 482.46 USD |
-0.66
|
$113.89B 124.5B USD | $74 80.89 USD | $441.15 482.24 USD | $444.35 485.73 USD | $113.89B 124.5B USD | 30.67 | $14.39 15.73 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $441.15 482.24 USD |
-0.69
|
$113.84B 124.44B USD | $13 14.21 USD | $441.15 482.24 USD | $441.15 482.24 USD | $113.84B 124.44B USD | 30.67 | $14.38 15.72 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $440.7 481.74 USD |
-0.75
|
$113.72B 124.32B USD | $28 30.61 USD | $440.7 481.74 USD | $443.2 484.48 USD | $113.72B 124.32B USD | 30.58 | $14.41 15.75 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $977 1067.99 USD |
-1.01
|
$108.17B 118.24B USD | $0 0 USD | $977 1067.99 USD | $982.8 1074.33 USD | $108.17B 118.24B USD | 30.77 | $31.75 34.71 USD | |
| CSL Limited CSJA.F | $90.5 98.93 USD |
0
|
$88.6B 96.85B USD | $36 39.35 USD | $90.5 98.93 USD | $90.5 98.93 USD | $88.6B 96.85B USD | 38.02 | $2.38 2.6 USD | |
| CSL Limited CSJ.F | $182.82 199.85 USD |
+0.26
|
$88.6B 96.85B USD | $125 136.64 USD | $181.76 198.69 USD | $182.82 199.85 USD | $88.6B 96.85B USD | 38.48 | $4.75 5.19 USD | |
| CSL CMXHF | $192 — |
0
|
$95.97B — | $80 — | $192 — | $192 — | $95.97B — | 37.72 | $5.09 — | |
| Moderna, Inc. M1RN34.SA | $33.44 6.78 USD |
+0.21
|
$256.31B 51.95B USD | $16.98K 3.44K USD | $32.82 6.65 USD | $34.25 6.94 USD | $256.31B 51.95B USD | 0 | -$4.29 -0.8 USD | |
| Moderna, Inc. MRNA.MX | $2,168.05 128.38 USD |
-2.3
|
$839.25B 49.69B USD | $797 47.19 USD | $2,168 128.37 USD | $2,180 129.08 USD | $839.25B 49.69B USD | 0 | -$287.6 -17.03 USD | |
| Moderna, Inc. 0QF.MU | $113.58 124.16 USD |
0
|
$43.53B 47.58B USD | $43 47 USD | $113.58 124.16 USD | $113.58 124.16 USD | $43.53B 47.58B USD | 0 | -$14.57 -15.9 USD | |
| Moderna, Inc. MRNA.VI | $111.9 122.32 USD |
-1.03
|
$42.88B 46.88B USD | $168 183.65 USD | $111.9 122.32 USD | $113.94 124.55 USD | $42.88B 46.88B USD | 0 | -$14.59 -15.9 USD | |
| Moderna, Inc. 0QF.F | $111.34 121.71 USD |
-1.63
|
$42.67B 46.64B USD | $435 475.51 USD | $109.98 120.22 USD | $115 125.71 USD | $42.67B 46.64B USD | 0 | -$14.56 -15.9 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $727,000 548.77 USD |
-0.68
|
$51.74T 39.06B USD | $76K 57.37 USD | $724,000 546.5 USD | $734,000 554.05 USD | $51.74T 39.06B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $67.55 13.69 USD |
0
|
$170.89B 34.64B USD | $10 2.03 USD | $67.55 13.69 USD | $67.55 13.69 USD | $170.89B 34.64B USD | 0 | -$0.73 -0.1 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $225.9 246.94 USD |
-0.48
|
$28.71B 31.39B USD | $5 5.47 USD | $225.9 246.94 USD | $229.3 250.66 USD | $28.71B 31.39B USD | 0 | -$2.46 -2.6 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $6 6.56 USD | $227.2 248.36 USD | $227.2 248.36 USD | $27.27B 29.81B USD | 0 | -$7.12 -7.7 USD | |
| argenx SE A1RG34.SA | $86.11 17.45 USD |
0
|
$143.11B 29.01B USD | $0 0 USD | $86.11 17.45 USD | $86.11 17.45 USD | $143.11B 29.01B USD | 0 | -$31.26 -6.3 USD | |
| UCB SA UNC0.F | $68.5 74.88 USD |
+2.24
|
$26.32B 28.77B USD | $4 4.37 USD | $68.5 74.88 USD | $68.5 74.88 USD | $26.32B 28.77B USD | 77.84 | $0.88 0.96 USD | |
| UCB SA UCB.VI | $138.05 150.91 USD |
+0.18
|
$26.32B 28.77B USD | $0 0 USD | $138.05 150.91 USD | $138.05 150.91 USD | $26.32B 28.77B USD | 78.88 | $1.75 1.91 USD | |
| UCB SA UNC.F | $137.55 150.36 USD |
+0.36
|
$26.32B 28.77B USD | $349 381.5 USD | $137.55 150.36 USD | $137.55 150.36 USD | $26.32B 28.77B USD | 78.15 | $1.76 1.92 USD | |
| UCB SA UCBJF | $132.5 — |
0
|
$27.96B — | $623 — | $132 — | $132.5 — | $27.96B — | 70.85 | $1.87 — | |
| Celltrion, Inc. 068270.KS | $174,300 131.57 USD |
+0.29
|
$36.17T 27.3B USD | $331.35K 250.12 USD | $173,500 130.96 USD | $175,400 132.4 USD | $36.17T 27.3B USD | 0 | $0 0 USD | |
| argenx SE ARGX.VI | $419.1 458.13 USD |
-0.88
|
$24.91B 27.23B USD | $0 0 USD | $419.1 458.13 USD | $419.1 458.13 USD | $24.91B 27.23B USD | 0 | -$5.32 -5.8 USD | |
| argenx SE 1AE.F | $413.7 452.23 USD |
-0.19
|
$24.59B 26.88B USD | $14 15.3 USD | $413.7 452.23 USD | $413.7 452.23 USD | $24.59B 26.88B USD | 0 | -$5.3 -5.7 USD | |
| argenx SE 1AEA.F | $412 450.37 USD |
0
|
$24.49B 26.77B USD | $10 10.93 USD | $412 450.37 USD | $412 450.37 USD | $24.49B 26.77B USD | 0 | -$5.31 -5.8 USD | |
| argenx SE ARGNF | $373.5 — |
0
|
$26.43B — | $1K — | $373.5 — | $373.5 — | $26.43B — | 0 | -$5.68 — | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $77 84.17 USD | $331 361.83 USD | $331 361.83 USD | $21.66B 23.68B USD | 68.12 | $4.86 5.31 USD | |
| BioNTech SE 0A3M.IL | $80.8 — |
-0.71
|
$22.23B — | $2.43K — | $80.24 — | $81.28 — | $22.23B — | 4.48 | $18 — | |
| BioNTech SE B1NT34.SA | $28.14 5.7 USD |
+1.19
|
$108.5B 21.99B USD | $260 52.7 USD | $28.03 5.68 USD | $28.21 5.72 USD | $108.5B 21.99B USD | 165.52 | $0.17 0.03 USD | |
| Genmab A/S 0MGB.IL | $1,737.25 254.72 USD |
-2.8
|
$139.12B 20.4B USD | $3.98K 583.85 USD | $1,737 254.68 USD | $1,791 262.6 USD | $139.12B 20.4B USD | 24.54 | $70.77 10.38 USD | |
| BioNTech SE BNTX.VI | $75.45 82.48 USD |
-0.79
|
$18.18B 19.88B USD | $0 0 USD | $75.45 82.48 USD | $75.55 82.59 USD | $18.18B 19.88B USD | 160.53 | $0.47 0.51 USD | |
| BioNTech SE 22UA.F | $75.3 82.31 USD |
+0.4
|
$18.15B 19.84B USD | $469 512.68 USD | $75.2 82.2 USD | $76 83.08 USD | $18.15B 19.84B USD | 160.21 | $0.47 0.51 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $233.67 47.36 USD |
0
|
$88.74B 17.99B USD | $0 0 USD | $233.67 47.36 USD | $233.67 47.36 USD | $88.74B 17.99B USD | 80.02 | $2.92 0.59 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,565 92.67 USD |
0
|
$297.16B 17.6B USD | $0 0 USD | $1,565 92.67 USD | $1,565 92.67 USD | $297.16B 17.6B USD | 80.01 | $19.56 1.16 USD | |
| BeiGene, Ltd. B1GN34.SA | $31.93 6.47 USD |
0
|
$86.11B 17.45B USD | $3 0.61 USD | $31.93 6.47 USD | $31.93 6.47 USD | $86.11B 17.45B USD | 0 | -$3.21 -0.6 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $44.4 9 USD |
+1.93
|
$83.94B 17.01B USD | $3.08K 624.27 USD | $43.5 8.82 USD | $44.72 9.06 USD | $83.94B 17.01B USD | 370.00 | $0.12 0.02 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $23 25.14 USD | $80.76 88.28 USD | $81.08 88.63 USD | $15.26B 16.68B USD | 115.74 | $0.7 0.77 USD | |
| Genmab A/S GNMSF | $255.55 — |
-0.37
|
$16.55B — | $1 — | $255.55 — | $255.55 — | $16.55B — | 21.51 | $11.88 — | |
| Genmab A/S GMAB.VI | $234.7 256.56 USD |
-1.68
|
$14.9B 16.28B USD | $0 0 USD | $234.7 256.56 USD | $237.8 259.95 USD | $14.9B 16.28B USD | 21.10 | $11.12 12.16 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $77.98 85.24 USD |
+0.67
|
$14.81B 16.19B USD | $5 5.47 USD | $77.98 85.24 USD | $77.98 85.24 USD | $14.81B 16.19B USD | 78.76 | $0.99 1.08 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $77.64 84.87 USD |
+0.36
|
$14.74B 16.12B USD | $0 0 USD | $77.64 84.87 USD | $78.28 85.57 USD | $14.74B 16.12B USD | 78.42 | $0.99 1.08 USD | |
| BeiGene, Ltd. 49B.F | $10.1 11.04 USD |
+1
|
$14.74B 16.11B USD | $12 13.12 USD | $10.1 11.04 USD | $10.1 11.04 USD | $14.74B 16.11B USD | 0 | -$0.54 -0.5 USD | |
| Royalty Pharma plc RPD.MU | $25.07 27.4 USD |
0
|
$14.7B 16.07B USD | $100 109.31 USD | $25.07 27.4 USD | $25.07 27.4 USD | $14.7B 16.07B USD | 15.10 | $1.66 1.81 USD | |
| Royalty Pharma plc RPD.F | $24.71 27.01 USD |
-3.02
|
$14.7B 16.07B USD | $260 284.22 USD | $24.71 27.01 USD | $24.71 27.01 USD | $14.7B 16.07B USD | 14.88 | $1.66 1.81 USD | |
| BeiGene, Ltd. 49BA.F | $135 147.57 USD |
0
|
$14.7B 16.07B USD | $26 28.42 USD | $135 147.57 USD | $135 147.57 USD | $14.7B 16.07B USD | 0 | -$7.05 -7.7 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $147 160.69 USD |
+0.79
|
$13.92B 15.22B USD | $12 13.12 USD | $147 160.69 USD | $147 160.69 USD | $13.92B 15.22B USD | 367.50 | $0.4 0.44 USD | |
| United Therapeutics Corporation UTH.F | $295.1 322.58 USD |
-0.1
|
$13.2B 14.43B USD | $15 16.4 USD | $295.1 322.58 USD | $295.1 322.58 USD | $13.2B 14.43B USD | 14.97 | $19.71 21.55 USD | |
| Incyte Corporation I1NC34.SA | $167.5 33.95 USD |
0
|
$66B 13.38B USD | $0 0 USD | $167.5 33.95 USD | $167.5 33.95 USD | $66B 13.38B USD | 18.44 | $9.08 1.84 USD | |
| Incyte Corporation INCY.MX | $1,096.52 64.93 USD |
0
|
$220.24B 13.04B USD | $0 0 USD | $1,096.52 64.93 USD | $1,096.52 64.93 USD | $220.24B 13.04B USD | 18.01 | $60.86 3.6 USD | |
| Bio-Techne Corporation T1CH34.SA | $13.38 2.71 USD |
0
|
$63.25B 12.82B USD | $0 0 USD | $13.38 2.71 USD | $13.38 2.71 USD | $63.25B 12.82B USD | 58.17 | $0.23 0.05 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Incyte Corporation ICY.F | $57.24 62.57 USD |
-0.59
|
$11.28B 12.33B USD | $290 317.01 USD | $57.24 62.57 USD | $57.24 62.57 USD | $11.28B 12.33B USD | 18.58 | $3.08 3.37 USD | |
| Bio-Techne Corporation TECH.MX | $1,310.32 77.59 USD |
-2.54
|
$206.49B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $206.49B 12.23B USD | 51.58 | $25.4 1.5 USD | |
| Bio-Techne Corporation TE1.F | $66 72.15 USD |
-1.49
|
$10.53B 11.52B USD | $2 2.19 USD | $66 72.15 USD | $67 73.24 USD | $10.53B 11.52B USD | 56.41 | $1.17 1.28 USD | |
| Insmed Incorporated IM8N.SG | $62.5 68.32 USD |
0
|
$10.21B 11.16B USD | $0 0 USD | $62.5 68.32 USD | $62.5 68.32 USD | $10.21B 11.16B USD | 0 | -$4.88 -5.3 USD | |
| Insmed Incorporated IM8N.F | $62.5 68.32 USD |
-3.1
|
$10.21B 11.16B USD | $74 80.89 USD | $62.5 68.32 USD | $62.5 68.32 USD | $10.21B 11.16B USD | 0 | -$4.88 -5.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| Vaxcyte, Inc. 5VA.F | $73.5 80.35 USD |
+6.52
|
$8B 8.74B USD | $4 4.37 USD | $73.5 80.35 USD | $73.5 80.35 USD | $8B 8.74B USD | 0 | -$4.01 -4.3 USD | |
| Vaxcyte, Inc. 5VA.MU | $73.5 80.35 USD |
+5
|
$8B 8.74B USD | $10 10.93 USD | $73.5 80.35 USD | $73.5 80.35 USD | $8B 8.74B USD | 0 | -$4.01 -4.3 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Ascendis Pharma A/S A1SN34.SA | $45.1 9.14 USD |
0
|
$42.89B 8.69B USD | $0 0 USD | $45.1 9.14 USD | $45.1 9.14 USD | $42.89B 8.69B USD | 0 | -$52.27 -10.5 USD | |
| Legend Biotech Corporation 9LB.F | $41 44.82 USD |
-0.97
|
$7.54B 8.24B USD | $50 54.66 USD | $41 44.82 USD | $41.4 45.26 USD | $7.54B 8.24B USD | 0 | -$2.41 -2.6 USD | |
| Roivant Sciences Ltd. 87S.F | $9.42 10.29 USD |
+0.58
|
$7.29B 7.97B USD | $500 546.57 USD | $9.42 10.29 USD | $9.43 10.31 USD | $7.29B 7.97B USD | 1.92 | $4.88 5.33 USD | |
| Ascendis Pharma A/S A71.F | $126 137.74 USD |
+1.61
|
$7.28B 7.95B USD | $1K 1.09K USD | $126 137.74 USD | $126 137.74 USD | $7.28B 7.95B USD | 0 | -$8.87 -9.6 USD | |
| Zealand Pharma A/S ZLDPF | $125.5 — |
+0.24
|
$7.82B — | $2K — | $125.5 — | $125.5 — | $7.82B — | 0 | -$1.77 — | |
| Innovent Biologics, Inc. 6IB.F | $4.2 4.59 USD |
-5.83
|
$7.14B 7.8B USD | $130 142.11 USD | $4.2 4.59 USD | $4.38 4.79 USD | $7.14B 7.8B USD | 0 | -$0.08 -0.08 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.37B 7.78B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.37B 7.78B USD | 0 | -$42.65 -2.5 USD | |
| Innovent Biologics IVBXF | $4.74 — |
-5.2
|
$7.7B — | $304 — | $4.74 — | $4.74 — | $7.7B — | 0 | -$0.09 — | |
| Sino Biopharmaceutical Limited SBMFF | $0.3699 — |
+16.05
|
$7.55B — | $1.89K — | $0.3699 — | $0.3699 — | $7.55B — | 36.54 | $0.01 — | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $43.99 48.09 USD |
-1.01
|
$6.5B 7.1B USD | $100 109.31 USD | $43.99 48.09 USD | $43.99 48.09 USD | $6.5B 7.1B USD | 0 | -$2.49 -2.7 USD | |
| Blueprint Medicines Corporation 2L9.F | $101.9 111.39 USD |
+6.63
|
$6.38B 6.97B USD | $12 13.12 USD | $100.15 109.48 USD | $101.9 111.39 USD | $6.38B 6.97B USD | 0 | -$4.5 -4.9 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $99.58 108.85 USD |
+0.06
|
$6.29B 6.87B USD | $1 1.09 USD | $99.08 108.31 USD | $99.78 109.07 USD | $6.29B 6.87B USD | 22.07 | $4.51 4.93 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $48.13 52.61 USD |
-1.07
|
$6.23B 6.81B USD | $300 327.94 USD | $48.13 52.61 USD | $48.13 52.61 USD | $6.23B 6.81B USD | 21.39 | $2.25 2.46 USD | |
| Exelixis, Inc. EX9.F | $20.89 22.84 USD |
+1.02
|
$6.11B 6.68B USD | $500 546.57 USD | $20.89 22.84 USD | $20.89 22.84 USD | $6.11B 6.68B USD | 34.24 | $0.61 0.67 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $2.88 3.15 USD |
+6.67
|
$5.98B 6.53B USD | $600 655.88 USD | $2.66 2.91 USD | $2.88 3.15 USD | $5.98B 6.53B USD | 14.40 | $0.2 0.22 USD | |
| Sino Biopharmaceutical SBHMY | $6.78 — |
0
|
$6.51B — | $1 — | $6.78 — | $6.78 — | $6.51B — | 24.21 | $0.28 — | |
| Revolution Medicines, Inc. 42Z.F | $35.8 39.13 USD |
0
|
$5.95B 6.51B USD | $25 27.33 USD | $35.8 39.13 USD | $35.8 39.13 USD | $5.95B 6.51B USD | 0 | -$3.59 -3.9 USD | |
| Cytokinetics, Incorporated KK3A.F | $49.4 54 USD |
-0.8
|
$5.93B 6.48B USD | $80 87.45 USD | $49.4 54 USD | $49.8 54.44 USD | $5.93B 6.48B USD | 0 | -$5.04 -5.5 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.37 1.5 USD |
-0.81
|
$5.73B 6.26B USD | $208 227.37 USD | $1.37 1.5 USD | $1.37 1.5 USD | $5.73B 6.26B USD | 13.69 | $0.1 0.11 USD | |
| Viking Therapeutics, Inc. 1VT.F | $50.9 55.64 USD |
+11.82
|
$5.61B 6.14B USD | $1.26K 1.37K USD | $47.8 52.25 USD | $50.9 55.64 USD | $5.61B 6.14B USD | 0 | -$0.86 -0.9 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $260.7 284.98 USD |
-1.77
|
$5.58B 6.1B USD | $10 10.93 USD | $259.6 283.78 USD | $264.5 289.13 USD | $5.58B 6.1B USD | 0 | -$21.6 -23.6 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Krystal Biotech, Inc. 4KB.F | $170 185.83 USD |
+0.95
|
$4.94B 5.4B USD | $41 44.82 USD | $170 185.83 USD | $170 185.83 USD | $4.94B 5.4B USD | 83.33 | $2.04 2.23 USD | |
| Krystal Biotech, Inc. 4KB.SG | $169.45 185.23 USD |
+0.44
|
$4.91B 5.37B USD | $0 0 USD | $169.45 185.23 USD | $170.05 185.89 USD | $4.91B 5.37B USD | 83.06 | $2.04 2.23 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$86.55B 5.12B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $86.55B 5.12B USD | 21.27 | $31.96 1.89 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| ALK-Abelló A/S AKBLF | $21.17 — |
0
|
$5.07B — | $1K — | $21.17 — | $21.17 — | $5.07B — | 57.21 | $0.37 — | |
| Financière de Tubize SA FTD.F | $102.6 112.16 USD |
-0.19
|
$4.64B 5.07B USD | $96 104.94 USD | $102.6 112.16 USD | $102.6 112.16 USD | $4.64B 5.07B USD | 51.81 | $1.98 2.16 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||